8:40 Panel Discussion: Reflecting on Lessons Learned from PhII/III Failures to Drive Urgency for Novel CNS Biomarker Research
Time: 8:45 am
day: Conference Day 1
Details:
- Evaluating past failures to identify key missteps, avoid repeating errors, and foster collective learning that propels the field forward with greater cohesion
- The blood-based biomarker revolution: Reviewing the latest progress to increase accessibility, sensitivity and scalability
- Evaluating the latest progress in neuroimaging technologies: Enhancing clinical value, navigating constraints, and integrating with fluid-based approaches
